In Veritas Medical Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVME research report →
Price Chart
About the company
In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes.
- CEO
- G. T. Cooper
- IPO
- 2004
- Employees
- 7
- HQ
- Inverness, GB
Get TickerSpark's AI analysis on IVME
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $60.23K
- P/E
- -0.54
- PEG
- -0.48
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -34.02
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 1.86%
- ROIC
- 3.23%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-107,800
- Net Income
- $-107,800+0.0%
- EPS
- $-0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.30
- 52W Low
- $0.00
- 50D MA
- $0.19
- 200D MA
- $0.10
- Beta
- 7.80
- RSI (14)
- 32
- Avg Volume
- 5
No earnings-call transcripts are available for IVME yet.
- Free Float
- 60.4%
- Shares Outstanding
- 86.05M
- Float Shares
- 52.01M
Our IVME coverage
Recent articles, reports, and earnings notes.
No research on IVME yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVME report →